| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
58,867 |
53,485 |
$3.92M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,496 |
15,914 |
$788K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,604 |
4,797 |
$487K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,926 |
3,797 |
$468K |
| 80053 |
Comprehensive metabolic panel |
22,326 |
19,484 |
$222K |
| 80050 |
General health panel |
3,648 |
3,609 |
$186K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,903 |
19,172 |
$169K |
| 36415 |
Collection of venous blood by venipuncture |
39,245 |
34,105 |
$167K |
| 99205 |
Prolong outpt/office vis |
856 |
837 |
$128K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,233 |
1,169 |
$124K |
| 80061 |
Lipid panel |
9,444 |
9,193 |
$119K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
81 |
76 |
$111K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,352 |
3,270 |
$101K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,723 |
2,652 |
$77K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,933 |
6,750 |
$62K |
| 99215 |
Prolong outpt/office vis |
565 |
523 |
$60K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
669 |
641 |
$50K |
| 84439 |
|
4,642 |
4,499 |
$41K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
12 |
12 |
$41K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,234 |
2,164 |
$35K |
| 99442 |
|
484 |
456 |
$35K |
| 86235 |
|
330 |
226 |
$35K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
49 |
28 |
$31K |
| 83615 |
|
5,108 |
4,133 |
$30K |
| 82728 |
|
2,397 |
2,293 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,736 |
2,033 |
$30K |
| 86140 |
|
5,630 |
5,481 |
$28K |
| 86480 |
|
315 |
309 |
$21K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
20 |
12 |
$19K |
| 83550 |
|
2,187 |
2,097 |
$17K |
| 80074 |
|
337 |
330 |
$17K |
| 93000 |
|
1,818 |
1,731 |
$17K |
| 86147 |
|
291 |
197 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
170 |
162 |
$16K |
| 99441 |
|
429 |
423 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
295 |
248 |
$15K |
| 99443 |
|
172 |
164 |
$15K |
| 86146 |
|
254 |
172 |
$15K |
| 83540 |
|
2,214 |
2,120 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,511 |
1,484 |
$13K |
| 20610 |
|
257 |
229 |
$12K |
| 82570 |
|
2,211 |
2,082 |
$11K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
28 |
28 |
$11K |
| 81001 |
|
3,571 |
3,403 |
$10K |
| 84481 |
|
594 |
589 |
$10K |
| 73620 |
|
584 |
284 |
$10K |
| 82043 |
|
1,705 |
1,667 |
$9K |
| J3490 |
Unclassified drugs |
5,332 |
3,595 |
$9K |
| 73630 |
|
392 |
294 |
$9K |
| 73120 |
|
577 |
278 |
$9K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,208 |
1,265 |
$9K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,836 |
1,704 |
$8K |
| 86160 |
|
440 |
298 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
383 |
379 |
$8K |
| 36591 |
|
670 |
395 |
$7K |
| 83970 |
|
137 |
136 |
$7K |
| 85652 |
|
2,309 |
2,239 |
$6K |
| 86200 |
|
424 |
415 |
$6K |
| 96415 |
|
191 |
142 |
$5K |
| 82607 |
|
334 |
327 |
$5K |
| 90686 |
|
332 |
328 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
479 |
427 |
$5K |
| 82378 |
|
261 |
211 |
$4K |
| 84550 |
|
1,161 |
1,100 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
118 |
111 |
$4K |
| 74178 |
|
29 |
27 |
$4K |
| 85045 |
|
1,161 |
1,071 |
$4K |
| 86225 |
|
257 |
248 |
$4K |
| 86038 |
|
284 |
274 |
$4K |
| 96417 |
|
50 |
37 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,092 |
3,174 |
$4K |
| 90674 |
|
217 |
216 |
$4K |
| 90670 |
|
14 |
14 |
$3K |
| 83516 |
|
221 |
204 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
63 |
29 |
$3K |
| 73130 |
|
66 |
32 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
57 |
43 |
$2K |
| 81025 |
|
274 |
262 |
$2K |
| 93458 |
|
13 |
12 |
$2K |
| 86431 |
|
381 |
372 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
14 |
$2K |
| 99422 |
|
32 |
29 |
$2K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
155 |
102 |
$2K |
| 71270 |
|
12 |
12 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
54 |
52 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,406 |
1,878 |
$2K |
| 20604 |
|
28 |
24 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
73 |
72 |
$1K |
| 83735 |
|
248 |
229 |
$1K |
| 76881 |
|
18 |
15 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,063 |
1,776 |
$1K |
| 80069 |
|
163 |
127 |
$1K |
| 80076 |
|
131 |
124 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
17 |
$966.51 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$919.90 |
| 99423 |
|
12 |
12 |
$777.32 |
| 85613 |
|
78 |
76 |
$769.91 |
| 84156 |
|
214 |
204 |
$742.77 |
| 76942 |
|
13 |
12 |
$740.27 |
| 83520 |
|
35 |
33 |
$691.34 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
138 |
105 |
$687.89 |
| 93015 |
|
12 |
12 |
$674.95 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
177 |
157 |
$674.50 |
| 82172 |
|
31 |
26 |
$655.67 |
| 82550 |
|
74 |
72 |
$596.91 |
| 20550 |
|
13 |
13 |
$591.65 |
| 82746 |
|
37 |
36 |
$591.33 |
| 96523 |
|
46 |
38 |
$553.11 |
| 82565 |
|
96 |
90 |
$494.58 |
| 85730 |
|
65 |
63 |
$393.42 |
| 82248 |
|
81 |
78 |
$387.23 |
| 86039 |
|
35 |
35 |
$379.50 |
| 85610 |
|
78 |
66 |
$321.70 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15 |
14 |
$236.63 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
112 |
99 |
$147.98 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
52 |
43 |
$136.25 |
| 84100 |
|
33 |
24 |
$122.69 |
| 90756 |
|
14 |
14 |
$122.09 |
| 84436 |
|
18 |
18 |
$121.24 |
| 84479 |
|
18 |
17 |
$107.52 |
| 87088 |
|
12 |
12 |
$96.35 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$96.17 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
12 |
12 |
$56.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$9.13 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
421 |
366 |
$4.64 |
| 4004F |
|
56 |
53 |
$0.00 |
| G9225 |
Foot exam was not performed, reason not given |
42 |
40 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
89 |
86 |
$0.00 |